News Headlines For the second time in less than six months, the Food and Drug Administration (FDA) is being questioned on its ability to regulate the safety of medical devices. Many are asking why the agency has allowed the INRatio monitor, a blood-testing device, to remain on the market after thousands of malfunctions and injuries reports. A good job is its own reward, but that doesn't mean recognition isn't appreciated. Last year, 1,043 hospitals (31.5% of those analyzed) were recognized by The Joint Commission's Top Performer on Key Quality Measures® program. Inclusion on the top performers' list is a huge source of pride for many facilities, with those who've made the cut proudly announcing their success on websites and foyer walls. Which is why The Joint Commission's decision to place the program on hiatus in 2016 has caused a stir in the accreditation world. The Centers for Disease Control and Prevention (CDC) finally published its Guideline for Prescribing Opioids for Chronic Pain on March 15. However, the guidelines are voluntary and after months of protests, some question how many in the healthcare sector will adopt them.
Marketing Spotlight The newest version of HCPro’s premier survey prep guide, this updated edition lets you thoroughly train your entire organization on the most up-to-date standards, ensuring everyone is ready when surveyors walk through your front door. Save yourself time and effort in preparing your organization—this toolkit does the prep work for you! Click here for a free excerpt on survey preparedness tips!
Editor's Picks March 22, 2016 March 1, 2016
Stay Connected to HCPro Don't Miss the News You Want. Spam filters exist for a reason, but not for the news you need. Make sure you aren’t missing your weekly industry coverage. Add our address -- [email protected] -- to your address book or e-mail whitelist to keep the news you need in your inbox. Is All of Your Team In The Know? Our weekly e-newsletters can keep your team abreast of up-to-date industry information; including expert analysis where you need it most. Subscribe to any -- or all -- of our e-newsletters. |